Goldan Keith A. 4
4 · Syndax Pharmaceuticals Inc · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-06-14$20.03/sh+1,250$25,037→ 52,623 total
4 · Syndax Pharmaceuticals Inc · Filed Jun 17, 2024
Common Stock